Latest Boehringer Ingelheim Stories
New data analyses further examine efficacy and safety across all GOLD categories, as well as COPD patients beginning or already on a maintenance therapy, including inhaled corticosteroids (ICS) DENVER,
Long-term OFEV treatment in the INPULSIS® extension study reinforces the safety and tolerability profile for up to 33 months in patients with IPF RIDGEFIELD, Conn., May 18, 2015 /PRNewswire/
FRENCHS FOREST, Australia and INGELHEIM, Germany, May 18, 2015 /PRNewswire/ -- -- Boehringer Ingelheim exercises option and acquires global ownership of Pharmaxis'
RIDGEFIELD, Conn., and SACRAMENTO, Calif., May 11, 2015 /PRNewswire/ -- Boehringer Ingelheim, a family-owned biopharmaceutical company, and Sutter Health, a not-for-profit health system in Northern
WASHINGTON, May 5, 2015 /PRNewswire/ -- A coalition of 11 leading companies involved in the development and manufacturing of biopharmaceuticals and "biosimilar" medicines today announced the
ALEXANDRIA, Va., May 4, 2015 /PRNewswire-USNewswire/ -- The American Diabetes Association (Association) is pleased to announce the
- 60 percent of surveyed U.S.
Legal-Bay, Lawsuit Money Advance Firm, says Boehringer submitted a supplemental new drug application to the FDA for Pradaxa so it can be used to treat the prophylaxis of deep venous thrombosis (DVT)
VANCOUVER, British Columbia, March 31, 2015 /PRNewswire/ -- InMed Pharmaceuticals Inc.
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.